ArticleOncotarget2013

A Tumor initiating cell-enriched prognostic signature for HER2+:ERα- breast cancer; rationale, new features, controversies and future directions.

Jeff C Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.